Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQU5E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,135
Award facts
- Contract value 100% obligated
- $21,134.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,134.88 to AmerisourceBergen Drug Corp for the supply of Kesimpta 20 mg/0.4 ml pen auto-injectors on a firm fixed-price basis. The award was made on January 14, 2026, with an ultimate completion date of January 15, 2026, and the product will be delivered to the company's facility in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement needs across the Department of Defense and other government healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.999 billion prime contract vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Kesimpta is a specialty medication indicated for multiple sclerosis treatment, reflecting the breadth of therapeutic domains covered under the company's federal pharmaceutical supply agreement. The competitively awarded delivery order structure demonstrates AmerisourceBergen's capability to fulfill specialized medical supply requirements through an established, long-term contract vehicle with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26FQU5E?
SPE2DR26FQU5E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FQU5E worth?
The government has obligated $21,135 on SPE2DR26FQU5E.
Is contract SPE2DR26FQU5E an order under another contract?
Yes. SPE2DR26FQU5E is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU5E competed?
The extent of competition for SPE2DR26FQU5E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award